A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease

NCT07231679 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Chronic Kidney Disease

Interventions

DRUG: IGT-303
DRUG: Placebo

Sponsor

Ingenia Therapeutics INC